Press Releases and News

Monitoring protein aggregation in biotherapeutics – a hot topic at the 9th annual American Drug Delivery & Formulation Summit

October 21, 2019

We recently exhibited at the 9th annual American Drug Delivery & Formulation Summit, in Boston MA. The Summit focused on challenges of developing biopharmaceutical formulations, and the latest trends and technologies to improve drug delivery. The key message was encouraging a drug delivery mind-set from discovery through to production.  Researchers learned about formulation design, optimizing formulation … “Monitoring protein aggregation in biotherapeutics – a hot topic at the 9th annual American Drug Delivery & Formulation Summit”

Protein Aggregation Monitoring was Hot Topic at Bioprocessing Summit

August 23, 2019

We have just returned from Bioprocessing Summit 2019 in our hometown of Boston. Over 1400 industry professionals attended a mixture of talks, posters and networking. Our booth was a popular destination, with many visitors stopping by to learn more about the AQS3TMpro. A hot topic at the conference was monitoring protein aggregation, the process by … “Protein Aggregation Monitoring was Hot Topic at Bioprocessing Summit”

Researchers From Numerous Disciplines Gather At The Colorado Protein Stability Conference

August 20, 2019

The 25th Anniversary Colorado Protein Stability Conference focused on protein stability and aggregation from a range of perspectives including computational modeling risk management, and formulation development. Researchers from numerous disciplines, ranging from biochemical research and clinical biochemistry to pharmaceutical development and manufacturing. The poster sessions were particularly lively, with many people stopping by to see … “Researchers From Numerous Disciplines Gather At The Colorado Protein Stability Conference”

RedShiftBio’s AQS³pro Changes the Game in the Detection and Treatment of Alzheimer’s

May 7, 2019

RedShift Bioanalytics’ instrumentation was crucial in ground-breaking developments in the detection and treatment of Alzheimer’s Disease (AD). The AQS3 TMpro, based on the company’s proprietary Microfluidic Modulation Spectroscopy, provided scientists from the University of Washington insight into the formation of small amyloid beta aggregates, the elements now believed to cause cognitive impairment typical in AD.

Inspiring innovative biotherapeutic protein drug development at PEGS 2019

April 23, 2019

One year on from introducing the AQS3TMpro, a powerful new protein characterization solution, we demonstrated compelling new application data and significant endorsements from leading biopharmaceutical companies at PEGS 2019. Driven by industry-leading AQS3delta analytical software, the AQS3pro is transforming the utility of IR spectroscopy for the analysis of protein structure, delivering high sensitivity results in … “Inspiring innovative biotherapeutic protein drug development at PEGS 2019”

Scientists See Change in Higher Order Structure with MMS, at HOS 2019

April 23, 2019

HOS 2019 highlighted the range of biophysical characterization methods and tools used in monitoring the attributes of protein therapeutics such as conformation and higher order structure. We showcased AQSpro with Microfluidic Modulation Spectroscopy (MMS), a system that addresses the limitations of current products such as FTIR, and provides an efficient tool for direct, label-free protein … “Scientists See Change in Higher Order Structure with MMS, at HOS 2019”

RedShiftBio Shipping AQS³pro as Industry Endorsements Expand

April 3, 2019

One year on from introducing the AQS3pro, a powerful new protein characterization platform, RedShift™ BioAnalytics, Inc. (RedShiftBio) is demonstrating compelling new application data and significant endorsements from leading biopharmaceutical companies.

Higher Order Structure: The Hot Topic of Biotherapeutics Analytical Summit

March 13, 2019

We have just returned from the Biotherapeutics Analytical Summit in Virginia. What a great celebration of the conference’s 10th birthday! We were inundated with fascinating conversations, the most popular being the characterization of higher order structure (or HOS). We presented a poster with Elion Labs on the study of HOS of IgG Samples Spiked with … “Higher Order Structure: The Hot Topic of Biotherapeutics Analytical Summit”

RedShiftBio Joined Thought Leaders at Biotherapeutics and Vaccines Development (Gordon Research Conference)

February 15, 2019

Critical Quality Attributes to Advance Therapeutics and Vaccines from Candidate Selection to Drug Product Biotherapeutics and vaccines are critical in improving public health. They are being developed for acute and chronic clinical indications that cover the spectrum from infectious diseases to oncology. The development of biologics, from candidate engineering and selection, through expression, purification, formulation, … “RedShiftBio Joined Thought Leaders at Biotherapeutics and Vaccines Development (Gordon Research Conference)”

RedShiftBio Shines at PepTalk 2019

February 15, 2019

We were excited to exhibit at PepTalk 2019 for the first time. PepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. The international delegation of over 1,300 participants attended for intensive learning and networking to discover new opportunities, apply alternative solutions, and develop promising partnerships. … “RedShiftBio Shines at PepTalk 2019”